Aldactone and Fistula - a phase IV clinical study of FDA data

Summary:

Fistula is reported as a side effect among people who take Aldactone (spironolactone), especially for people who are female, 60+ old, also take Celebrex, and have Crohn's disease.

The phase IV clinical study analyzes which people have Fistula when taking Aldactone. It is created by eHealthMe based on reports of 45,404 people who have side effects when taking Aldactone from the FDA, and is updated regularly.

What is Aldactone?

Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 46,063 Aldactone users. Check the latest studies of Aldactone.

What is Fistula?

Fistula (an abnormal connection or passageway between two) is found to be associated with 842 drugs and 906 conditions by eHealthMe. Check the latest studies of Fistula.

On Jul, 29, 2026

45,404 people reported to have side effects when taking Aldactone.
Among them, 15 people (0.03%) have Fistula.

Among these 15 people:

What is the gender of people who have Fistula when taking Aldactone? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Fistula when taking Aldactone? *

What are other drugs people take besides Aldactone? *

What are other side effects people have besides Fistula? *

Pain: 7 people, 46.67%
Stress And Anxiety: 5 people, 33.33%
Osteonecrosis Of Jaw (death of bone of jaw): 4 people, 26.67%
Anal Fistula: 4 people, 26.67%
Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 4 people, 26.67%
Joint Pain: 4 people, 26.67%
Enlarged Heart: 4 people, 26.67%
Pathological Fracture (broken bone caused by disease): 4 people, 26.67%
Uveitis (inflammation of the uvea): 4 people, 26.67%
Sinus Disorder (disease of sinus): 4 people, 26.67%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 46.67%
Breast Cancer Metastatic: 3 people, 20.00%
Metastases To Bone (cancer spreads to bone): 3 people, 20.00%
Depression: 3 people, 20.00%
Diarrhea: 2 people, 13.33%
Back Pain: 2 people, 13.33%
Breast Cancer: 2 people, 13.33%
Diabetes: 1 person, 6.67%
Cardiac Disorder: 1 person, 6.67%
Cardiac Failure Congestive: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Aldactone and have Fistula?

- Check whether Fistula is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aldactone:

Aldactone (46,063 reports)

Fistula treatments and more:

Fistula (16,274 reports)

Browse all side effects of Aldactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fistula:

Fistula (842 drugs)

Browse all the conditions that are associated with Fistula:

Fistula (906 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone (the active ingredients of Aldactone) and Aldactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.